Nazik Hammad: At ESHO 4th annual conference, Dr Haimanot Kasahun discusses a case of agressive angiomyxoma in a young woman responding to endocrine therapy

Nazik Hammad shared a post on LinkedIn:

“Today at ESHO (Ethiopian Society of Hematology and Oncology) 4th annual conference, Dr Haimanot Kasahun discusses a case of agressive angiomyxoma in a young woman responding to endocrine therapy. Clinical pearls: role of systemic therapy and importance of oncofertility considerations in young women.”

Source: Nazik Hammad/LinkedIn

Nazik Hammad is a Sudanese Canadian Professor of medical oncology, at Saint Michael Hospital, Department of Medicine,  University of Toronto.  Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMIC) particularly in sub-Saharan Africa. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology,  women as health care professionals and cancer in conflict zones. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the Lancet Commission on Women, Power and Cancer.